237 related articles for article (PubMed ID: 32375735)
1. Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.
Bjelic-Radisic V; Fitzal F; Knauer M; Steger G; Egle D; Greil R; Schrenk P; Balic M; Singer C; Exner R; Soelkner L; Gnant M;
BMC Cancer; 2020 May; 20(1):392. PubMed ID: 32375735
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial.
Robson M; Ruddy KJ; Im SA; Senkus E; Xu B; Domchek SM; Masuda N; Li W; Tung N; Armstrong A; Delaloge S; Bannister W; Goessl C; Degboe A; Hettle R; Conte P
Eur J Cancer; 2019 Oct; 120():20-30. PubMed ID: 31446213
[TBL] [Abstract][Full Text] [Related]
3. Post treatment quality of life among Sri Lankan women with breast cancer.
Jayasinghe R; Fernando A; Jayarajah U; Seneviratne S
BMC Cancer; 2021 Mar; 21(1):305. PubMed ID: 33757446
[TBL] [Abstract][Full Text] [Related]
4. Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Fitzal F; Bjelic-Radisic V; Knauer M; Steger G; Hubalek M; Balic M; Singer C; Bartsch R; Schrenk P; Soelkner L; Greil R; Gnant M;
Ann Surg; 2019 Jun; 269(6):1163-1169. PubMed ID: 31082916
[TBL] [Abstract][Full Text] [Related]
5. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.
Garsa AA; Ferraro DJ; DeWees TA; Deshields TL; Margenthaler JA; Cyr AE; Naughton M; Aft R; Gillanders WE; Eberlein T; Matesa MA; Ochoa LL; Zoberi I
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1043-50. PubMed ID: 24161428
[TBL] [Abstract][Full Text] [Related]
6. Quality of Life among Breast Cancer Patients In Malaysia.
Ganesh S; Lye MS; Lau FN
Asian Pac J Cancer Prev; 2016; 17(4):1677-84. PubMed ID: 27221837
[TBL] [Abstract][Full Text] [Related]
7. Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
Brandberg Y; Johansson H; Hellström M; Gnant M; Möbus V; Greil R; Foukakis T; Bergh J;
Breast Cancer Res Treat; 2020 May; 181(1):87-96. PubMed ID: 32232698
[TBL] [Abstract][Full Text] [Related]
8. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT).
Volders JH; Haloua MH; Krekel NM; Negenborn VL; Kolk RH; Lopes Cardozo AM; Bosch AM; de Widt-Levert LM; van der Veen H; Rijna H; Taets van Amerongen AH; Jóźwiak K; Meijer S; van den Tol MP
Eur J Surg Oncol; 2017 Apr; 43(4):649-657. PubMed ID: 27916314
[TBL] [Abstract][Full Text] [Related]
10. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
Velikova G; Williams LJ; Willis S; Dixon JM; Loncaster J; Hatton M; Clarke J; Kunkler IH; Russell NS;
Lancet Oncol; 2018 Nov; 19(11):1516-1529. PubMed ID: 30337220
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.
Versmessen H; Vinh-Hung V; Van Parijs H; Miedema G; Voordeckers M; Adriaenssens N; Storme G; De Ridder M
BMC Cancer; 2012 Oct; 12():495. PubMed ID: 23098579
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data.
Oei SL; Thronicke A; Grieb G; Schad F; Groß J
Breast Cancer; 2023 Nov; 30(6):1008-1017. PubMed ID: 37587322
[TBL] [Abstract][Full Text] [Related]
14. The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q.
Soran A; Soyder A; Ozbas S; Ozmen V; Karanlik H; Igci A; Muslumanoglu M; Evrensel T; Canturk Z; Utkan Z; Ozaslan C; Uras C; Ugurlu U; Col C; Cabioglu N; Uzunkoy A; Gulluoglu BM; Erdem E; Konca C; Sezgin E;
Support Care Cancer; 2021 Jul; 29(7):3823-3830. PubMed ID: 33242163
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
16. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study.
Aerts L; Christiaens MR; Enzlin P; Neven P; Amant F
Breast; 2014 Oct; 23(5):629-36. PubMed ID: 25082211
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
19. Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.
Ettl J; Quek RGW; Lee KH; Rugo HS; Hurvitz S; Gonçalves A; Fehrenbacher L; Yerushalmi R; Mina LA; Martin M; Roché H; Im YH; Markova D; Bhattacharyya H; Hannah AL; Eiermann W; Blum JL; Litton JK
Ann Oncol; 2018 Sep; 29(9):1939-1947. PubMed ID: 30124753
[TBL] [Abstract][Full Text] [Related]
20. Cloud-Based Service Information System for Evaluating Quality of Life after Breast Cancer Surgery.
Kao HY; Wu WH; Liang TY; Lee KT; Hou MF; Shi HY
PLoS One; 2015; 10(9):e0139252. PubMed ID: 26422018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
